Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.3%

5 terminated/withdrawn out of 389 trials

Success Rate

92.9%

+6.4% vs industry average

Late-Stage Pipeline

11%

42 trials in Phase 3/4

Results Transparency

0%

0 of 65 completed trials have results

Key Signals

92 recruiting

Enrollment Performance

Analytics

N/A
105(42.2%)
Phase 2
58(23.3%)
Phase 1
39(15.7%)
Phase 4
23(9.2%)
Phase 3
19(7.6%)
Early Phase 1
5(2.0%)
249Total
N/A(105)
Phase 2(58)
Phase 1(39)
Phase 4(23)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (389)

Showing 20 of 389 trials
NCT07642518Not ApplicableNot Yet Recruiting

Transcutaneous Auricular Vagus Nerve Stimulation in Type 2 Diabetes With Mild Cognitive Impairment

Role: lead

NCT07642544Not Yet Recruiting

Effects of Different Secukinumab Maintenance Regimens on Long-Term Outcomes in Patients With Psoriasis

Role: lead

NCT07253389Not ApplicableRecruiting

Comparison of Underdilated Versus Standard TIPS in Preventing Variceal Rebleeding in Patients With Cirrhosis

Role: collaborator

NCT07632677Recruiting

Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

Role: lead

NCT07630597Not ApplicableRecruiting

Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Lifestyle Intervention

Role: lead

NCT07604688Recruiting

Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China

Role: collaborator

NCT07623213Not ApplicableNot Yet Recruiting

AI-Guided Intensified Follow-up After Surgery for Acute Type A Aortic Dissection

Role: collaborator

NCT07622693Active Not Recruiting

Beta-Blockers on Neoadjuvant Immunochemotherapy for Hypertensive Patients With Gastric Cancer

Role: collaborator

NCT05322330Phase 2Completed

Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma

Role: collaborator

NCT07619989Not ApplicableRecruiting

Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists

Role: lead

NCT07620223Not ApplicableRecruiting

Prophylactic Antibiotics in Preventing Surgical Site Infection After Hepatobiliary Surgery in High-Resistant Settings

Role: lead

NCT07612319Not ApplicableRecruiting

Romiplostim for Oral TPO-RA Resistant ITP

Role: collaborator

NCT07612163Recruiting

Clinical Efficacy and Population Pharmacokinetics of β-lactams in Cirrhotic Patients

Role: lead

NCT07234383Phase 1Not Yet Recruiting

Accelerated HEmodiafiltration in Severe Acute Diquat (AHEAD) Poisoning

Role: lead

NCT07399574Not Yet Recruiting

Diagnostic Accuracy of A Diquat Quantitative Detection Kit and A Portable Mass Spectrometry System for Quantifying Diquat Concentrations in Human Blood Samples

Role: lead

NCT06544083Recruiting

Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood

Role: collaborator

NCT07603128Recruiting

Multicenter Validation of a Risk Prediction Model for MDRGNB Infection

Role: lead

NCT05129904Active Not Recruiting

Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)

Role: collaborator

NCT07605039Not ApplicableNot Yet Recruiting

Structural Mechanisms of Dual-Target tDCS in Stroke Hemiparetic Hand

Role: lead

NCT07594574Not ApplicableActive Not Recruiting

Posterior Minimally Invasive Surgery for Treating Paralytic Scoliosis With Pelvic Obliquity in Children Following Spinal Cord Injury

Role: lead